Perspectives of CCK antagonists in pancreatic research. Part II. Experimental studies.
In this article, the effects of different classes of cholecystokinin (CCK) receptor antagonists in CCK-related physiological processes of the pancreas have been discussed. Both glutaramic acid derivatives and natural (benzodiazepine) analogs are potent, competitive antagonists of peripheral CCK receptors. These compounds thus provide a powerful tool for investigating the physiological and pharmacological actions of CCK in the gastrointestinal system, and have already clarified the role of CCK in pancreatic secretion and trophism or growth.
Takács
T
T
First Department of Medicine, Albert Szent-Györgyi Medical University, Szeged, Hungary.
Pap
A
A
D000818:Animals; D001569:Benzodiazepines / Q000494:pharmacology; D002766:Cholecystokinin / Q000502:physiology; D007656:Ketoglutaric Acids / Q000494:pharmacology; D010179:Pancreas / Q000187:drug effects / Q000254:growth & development / Q000502:physiology; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors* / Q000502:physiology
D007656:Ketoglutaric Acids; D011949:Receptors, Cholecystokinin; D001569:Benzodiazepines; C057563:glutaramic acid; D002766:Cholecystokinin